Close Menu

NEW YORK — Bionano Genomics said on Thursday that it has priced an $18 million public offering of stock and warrants.

The company also recently announced its participation in a project investigating the genetics of susceptibility to COVID-19.

Through the offering, the San Diego-based company will sell 54.5 million shares of its common stock — or prefunded warrants to purchase common stock in lieu thereof — along with warrants to purchase an additional 54.5 million common shares. Each share will be sold with one warrant for $.33.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.